RAB22A and neoplasm: In papillary thyroid carcinoma, thyroid follicular carcinoma, and medullary thyroid carcinoma, Rab22a was positively overexpressed in tumor tissues and negatively expressed in adjacent normal thyroid tissues or nodular goiters (Figure 1(b)).